Is St. Jude Children's Research Hospital a Good Charity?

**Analyst's Note (Deepak Meena):** *St. Jude presents a unique case study under the FundTracker model. While their total capital reserves are massive, my analysis of their financial reporting confirms that their cost-per-patient ratio remains fully justified given their research integration. Donors looking for raw distribution vs long-term clinical permanent assets can use our comparison breakdowns below.* St. Jude Children's Research Hospital raises more money annually than almost any other nonprofit in the United States. That scale invites scrutiny, and the scrutiny reveals a more complicated picture than the organization's marketing suggests. What St. Jude actually does St. Jude is a pediatric research hospital in Memphis, Tennessee focused on childhood cancer and other life-threatening diseases. It treats patients without charging families for treatment, travel, housing, or food. It also conducts and publishes research that other hospitals and researchers use globally. These are genuine and significant contributions to pediatric oncology. The financial picture St. Jude's parent organization, ALSAC, raises approximately $2 billion annually, making it one of the largest charity fundraising operations in the world. The hospital itself spends around $1 billion per year on operations. The gap between what is raised and what is spent has generated criticism — a significant portion of donations goes into an endowment that has grown to over $7 billion rather than directly into current patient care or research. This is not inherently wrong. Large endowments provide institutional stability and fund long-term research that cannot be supported by annual giving alone. But donors who give expecting their money to immediately treat a child with cancer should understand that a substantial portion of their donation may sit in an investment portfolio for years before being deployed. What charity evaluators say Charity Navigator gives St. Jude four stars. GiveWell has not evaluated St. Jude because its methodology focuses on global health interventions with measurable cost per life saved, and St. Jude operates in a context where that calculation does not apply cleanly. BBB Wise Giving Alliance finds St. Jude meets its accountability standards. The criticisms worth understanding Two criticisms of St. Jude appear consistently in serious donor research. First, the fundraising cost ratio. ALSAC spends heavily on direct mail, telemarketing, and celebrity campaigns to raise its $2 billion. Critics argue that the fundraising machinery consumes resources that could go to patients. St. Jude responds that the scale of fundraising enables the scale of research. Both are partially correct. Second, the question of reach. St. Jude treats approximately 10,000 patients per year at its Memphis campus. For a $2 billion annual fundraising operation, that is a high cost per patient served compared to organizations delivering interventions in lower-cost environments. Supporters argue that the research St. Jude publishes benefits far more children globally than the ones treated directly in Memphis. The published research is genuinely valuable and widely used. How to think about giving to St. Jude St. Jude is a legitimate, well-run organization doing real work in pediatric cancer research and treatment. The criticisms are real but do not indicate fraud or mismanagement — they indicate a large organization making institutional choices that reasonable donors can evaluate differently. If your priority is maximum lives saved per dollar globally, there are organizations that score better on that specific metric. If your priority is supporting pediatric cancer research and treatment in the United States with a highly accountable institution, St. Jude belongs on your short list. FundTracker tracks charitable organizations and fundraising campaigns with real-time trust scores so donors can compare options before giving. You can explore verified campaigns alongside St. Jude on our NGO rankings page.